Clinical trial

LRRK2 Mutation and Parkinson's Disease

NCT01424475

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-08-11

PhasePHASE1

Study timeline

Study start (actual)2011-08-11Date precision: day

Registry last updated2017-05-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

HealthyGENETIC

PKD PatientsGENETIC

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

CambridgeUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01424475 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.